Skip to main content
São Paulo Medical Journal logoLink to São Paulo Medical Journal
. 2013 Dec 1;131(6):432–435. doi: 10.1590/1516-3180.2013.1316541

Rhabdomyolysis as a manifestation of clomipramine poisoning

Rabdomiólise como manifestação de intoxicação por clomipramina

Nathalie Oliveira de Santana I,, Aécio Flávio Teixeira de Góis II
PMCID: PMC10871817  PMID: 24346784

Abstract

CONTEXT:

Tricyclic antidepressive agents are widely used in suicide attempts and present a variety of deleterious effects. Rhabdomyolysis is a rare complication of such poisoning.

CASE REPORT:

A 55-year-old woman ingested 120 pills of 25 mg clomipramine in a suicide attempt two days before admission. After gastric lavage in another emergency department on the day of intake, 80 pills were removed. On admission to our department, she was disoriented, complaining of a dry mouth and tremors at the extremities. An electrocardiogram showed a sinus rhythm with narrow QRS complexes. Laboratory results showed high creatine phosphokinase (CK = 15,094 U/l on admission; normal range = 26 to 140 U/l), hypocalcemia, slightly increased serum transaminases and mild metabolic acidosis. The patient's medical history included depression with previous suicide attempts, obsessive-compulsive disorder, hypothyroidism and osteoporosis. She presented cardiac arrest with pulseless electric activity for seven minutes and afterwards, without sedation, showed continuous side-to-side eye movement. She developed refractory hypotension, with need for vasopressors. Ceftriaxone and clindamycin administration was started because of a hypothesis of bronchoaspiration. The patient remained unresponsive even without sedation, with continuous side-to-side eye movement and a decerebrate posture. She died two months later. Rhabdomyolysis is a very rare complication of poisoning due to tricyclic drugs. It had only previously been described after an overdose of cyclobenzaprine, which has a toxicity profile similar to tricyclic drugs.

CONCLUSIONS:

Although arrhythmia is the most important complication, rhabdomyolysis should be investigated in cases of clomipramine poisoning.

Keywords: Clomipramine; Antidepressive agents, tricyclic; Rhabdomyolysis; Poisoning; Toxicology

INTRODUCTION

Tricyclic antidepressants are among the most commonly used drugs in suicide attempts, along with benzodiazepines, alcohol and acetaminophen, 1 surpassed only by analgesics. 2 , 3 Around 300 people die each year in the United Kingdom due to tricyclic poisoning. 4 Although the risk of suicide is the same between tricyclic drugs and other antidepressants, the death rates are higher when tricyclic drugs are used: 97% of all deaths due to antidepressant poisoning are caused by them. 5

The case reported here forms an example of the range of clomipramine toxicity, and highlights an extremely rare complication: rhabdomyolysis.

CASE REPORT

A 55-year-old woman was brought into the emergency room after reportedly ingesting 120 pills of 25 mg clomipramine in a suicide attempt two days before admission. Gastric lavage was performed a few hours after the ingestion in another emergency department, and 80 pills were removed. On admission to our service, she was awake, but disoriented, complaining of a dry mouth and tremors at the extremities. Her pupils were equal and reactive; she was dehydrated; and her vital signs were 86 bpm and 122/74 mmHg. An electrocardiogram showed a sinus rhythm with narrow QRS complexes.

Laboratory results showed high creatine phosphokinase (CK = 15,094 U/l on admission; normal range = 26 to 140 U/l), hypocalcemia (ionized calcium = 1.05 mmol/l; normal range = 1.15 to 1.32 mmol/l), slightly increased serum transaminases (alanine aminotransferase = 130 U/l, aspartate aminotransferase = 176 U/l; normal ranges are up to 31 and up to 32 U/l, respectively) and mild metabolic acidosis (bicarbonate content in venous blood = 19.5 mmol/l; normal range = 22 to 26 mmol/l). TSH and free T4 levels were within the normal ranges. Troponin I = 0.03 ng/ml (normal values are up to 0.04 ng/ml); urine analysis presented pH = 5.0.

The patient's medical history included depression with previous suicide attempts, obsessive-compulsive disorder, hypothyroidism and osteoporosis. The psychoactive drugs that had been used to treat depression were clomipramine and fluoxetine.

On the day of admission, the patient presented cardiac arrest with pulseless electric activity for seven minutes, which was treated in accordance with the Advanced Cardiac Life Support protocol, in the emergency department. A total of 100 mEq of sodium bicarbonate was administered. Spontaneous circulation returned, with sinus bradycardia and narrow QRS complexes, which were reversed with atropine. On the following day, after sedation was turned off, there was only a response to painful stimuli. The patient was admitted to the intensive care unit without sedation, showing continuous side-to-side eye movement. The tremors at the extremities and in the lips ceased after benzodiazepine administration. The first cranial computed tomography scan, produced two days after the cardiac arrest, showed signs of brain swelling, without cerebellar tonsil herniation.

The patient's urine was alkaline (pH = 7.0), and, since she had been receiving vigorous volume expansion since admission, acute renal failure did not occur. The creatine phosphokinase levels decreased and, one week after the ingestion, the CK level was 385 U/l.

A chest X-ray subsequent to the cardiac arrest revealed alveolar opacity in the left hemithorax and in the lower right hemithorax, and also diffuse bronchi and low PaO2/FiO2 ratio. Ceftriaxone and clindamycin administration was started because of a hypothesis of bronchoaspiration. The patient developed refractory hypotension, with the need for vasopressors.

Even after cessation of midazolam and fentanyl administration, the patient remained unresponsive, with continuous side-to-side eye movement and a decerebrate posture. Midazolam use was resumed, and was maintained continuously thereafter, in order to inhibit status epilepticus. The cranial computed tomography scan was repeated 48 hours after the first one, and no changes were observed. After it had been determined that the neurological prognosis was unfavorable due to anoxic brain damage, palliative care was instituted, and the patient died two months later.

DISCUSSION

Tricyclic toxicity is due to four main pharmacological properties: anticholinergic effect, noradrenaline reuptake inhibition, alpha adrenergic receptor blockade and quinidine-like effects that block sodium channels. 6 Despite conflicting data, 7 there seem to be differences in the toxic levels of tricyclic drugs, since it has been described that clomipramine, amitriptyline, imipramine and trimipramine present higher death rates. 8 , 9

Although data concerning the minimum toxic dose are scarce, some studies have correlated moderate toxicity with doses of 600 to 750 mg of clomipramine, while doses above 750 mg have been correlated with severe complications. 10 , 11 Our patient ingested a higher dose, (3,000 mg) that was capable of causing severe poisoning, even after gastric lavage. Decontamination brings benefits for up to one hour after ingestion, and there is no difference between gastric lavage and use of activated charcoal. 12 , 13

Inhibition of sodium channels delays depolarization, not only in the myocardium, but also in the conduction system. However, the incidence of severe dysrhythmias is low, ranging from 1.3% to 2.6%. 14 , 15 QRS duration (> 0.16 seconds) is a better predictor of ventricular dysrhythmias and seizures than is tricyclic plasma level itself, 16 and it is possible for a patient to present normal QRS duration in spite of a high tricyclic plasma level, 17 such as we have described in this case.

Late toxicity has been reported, mainly involving conduction disturbance, dysrhythmias and even death after clinical improvement and stabilization. 18 - 20 Nonetheless, it is not known whether these late effects are due to direct toxicity or to complications due to hospitalization.

It is important to highlight that rhabdomyolysis is a very rare complication of tricyclic antidepressive agents, 21 and its physiopathology has not been clarified yet (Table 1). It has been described after cyclobenzaprine overdose, which has a range of toxicity similar to that of tricyclic antidepressant overdoses. 22 , 23 Furthermore, there have been a few cases of serotonin syndrome that presented with rhabdomyolysis after an overdose of clomipramine and moclobemide. 24 , 25 In all of these cases, the treatment consists of removing the drug, which may require dialysis, and clinical support.

Table 1. Description of database search strategies.

Database Search strategy Results
Medline (Medical Literature Analysis and Retrieval System Online - via PubMed) ((antidepressive agents, tricyclic) OR Clomipramine) AND Rhabdomyolysis Filters: Case Reports 21 citations (2 related)
Lilacs (Literatura Latino-Americana e do Caribe em Ciências da Saúde - via Bireme) ((antidepressive agents, tricyclic) OR (antidepressivos tricíclicos) OR Clomipramine OR Clomipramina) AND (Rhabdomyolysis OR Rabdomiólise OR Rabdomiólisis) Filters: Case Reports None
Embase (Excerpta Medica Database - via Elsevier) #tricyclic antidepressant agent OR #clomipramine AND #rhabdomyolysis 13 citations (2 related)

Search date: January 30, 2013.

CONCLUSION

Tricyclic drugs are widely used in suicide attempts and present several toxic effects. Even though dysrhythmia is the most worrisome complication, rhabdomyolysis should be remembered and investigated in cases of clomipramine poisoning.

Footnotes

Hospital São Paulo (HSP), Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil

Sources of funding: None

REFERENCES

  • 1.Buckley NA, Whyte IM, Dawson AH, McManus PR, Ferguson NW. Self-poisoning in Newcastle, 1987-1992. Med J Aust. 1995;162(4):190–193. doi: 10.5694/j.1326-5377.1995.tb126020.x. [DOI] [PubMed] [Google Scholar]
  • 2.Obafunwa JO, Busuttil A. Deaths from substance overdose in the Lothian and Borders region of Scotland (1983-1991) Hum Exp Toxicol. 1994;13(6):401–406. doi: 10.1177/096032719401300606. [DOI] [PubMed] [Google Scholar]
  • 3.Coleridge J, Cameron PA, Drummer OH, McNeil JJ. Survey of drug-related deaths in Victoria. Med J Aust. 1992;157(7):459–462. doi: 10.5694/j.1326-5377.1992.tb137307.x. [DOI] [PubMed] [Google Scholar]
  • 4.Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ. 1995;310(6974):215–218. doi: 10.1136/bmj.310.6974.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ. 1995;310(6974):221–224. doi: 10.1136/bmj.310.6974.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236–241. doi: 10.1136/emj.18.4.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Crome P, Newman B. Fatal tricyclic antidepressant poisoning. J R Soc Med. 1979;72(9):649–653. doi: 10.1177/014107687907200905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Henry JA. A fatal toxicity index for antidepressant poisoning. Acta Psychiatr Scand Suppl. 1989;354:37–45. doi: 10.1111/j.1600-0447.1989.tb03045.x. [DOI] [PubMed] [Google Scholar]
  • 9.Farmer RD, Pinder RM. Why do fatal overdose rates vary between antidepressants? Acta Psychiatr Scand Suppl. 1989;354:25–35. doi: 10.1111/j.1600-0447.1989.tb03044.x. [DOI] [PubMed] [Google Scholar]
  • 10.Bramble MG, Lishman AH, Purdon J, Diffey BL, Hall RJ. An analysis of plasma levels and 24-hour ECG recordings in tricyclic antidepressant poisoning: implications for management. Q J Med. 1985;56(219):357–366. [PubMed] [Google Scholar]
  • 11.Roberge RJ, Martin TG, Hodgman M, Benitez JG. Acute chemical pancreatitis associated with a tricyclic antidepressant (clomipramine) overdose. J Toxicol Clin Toxicol. 1994;32(4):425–429. doi: 10.3109/15563659409011044. [DOI] [PubMed] [Google Scholar]
  • 12.Kulig W, Bar-Or D, Cantrill SV, Rosen P, Rumack BH. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med. 1985;14(6):562–567. doi: 10.1016/s0196-0644(85)80780-0. [DOI] [PubMed] [Google Scholar]
  • 13.Bosse GM, Barefoot JA, Pfeifer MP, Rodgers GC. Comparison of three methods of gut decontamination in tricyclic antidepressant overdose. J Emerg Med. 1995;13(2):203–209. doi: 10.1016/0736-4679(94)00153-7. [DOI] [PubMed] [Google Scholar]
  • 14.Thorstrand C. Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG. Acta Med Scand. 1976;199(5):337–344. doi: 10.1111/j.0954-6820.1976.tb06745.x. [DOI] [PubMed] [Google Scholar]
  • 15.Hultén BA, Heath A. Clinical aspects of tricyclic antidepressant poisoning. Acta Med Scand. 1983;213(4):275–278. doi: 10.1111/j.0954-6820.1983.tb03733.x. [DOI] [PubMed] [Google Scholar]
  • 16.Boehnert MT, Lovejoy FH Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med. 1985;313(8):474–479. doi: 10.1056/NEJM198508223130804. [DOI] [PubMed] [Google Scholar]
  • 17.Marshall JB. Tricyclic overdose. JAMA. 1980;244(17):1900–1900. [PubMed] [Google Scholar]
  • 18.Dale O, Hole A. Biphasic time-course of serum concentrations of clomipramine and desmethylclomipramine after a near-fatal overdose. Vet Hum Toxicol. 1994;36(4):309–310. [PubMed] [Google Scholar]
  • 19.Masters AB. Delayed death in imipramine poisoning. Br Med J. 1967;3(5569):866–867. doi: 10.1136/bmj.3.5569.866-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.McAlpine SB, Calabro JJ, Robinson MD, Burkle FM Jr. Late death in tricyclic antidepressant overdose revisited. Ann Emerg Med. 1986;15(11):1349–1352. doi: 10.1016/s0196-0644(86)80623-0. [DOI] [PubMed] [Google Scholar]
  • 21.Stevens E, Roman A, Houa M, Razavi D, Jaspar N. Severe hyperthermia during tetrabenazine therapy for tardive dyskinesia. Intensive Care Med. 1998;24(4):369–371. doi: 10.1007/s001340050583. [DOI] [PubMed] [Google Scholar]
  • 22.Chabria SB. Rhabdomyolysis: a manifestation of cyclobenzaprine toxicity. J Occup Med Toxicol. 2006;1:16–16. doi: 10.1186/1745-6673-1-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.O'Riordan W, Gillete P, Calderon J, Stennes RL. Overdose of cyclobenzaprine, the tricyclic muscle relaxant. Ann Emerg Med. 1986;15(5):592–593. doi: 10.1016/s0196-0644(86)80999-4. [DOI] [PubMed] [Google Scholar]
  • 24.François B, Marquet P, Desachy A, et al. Serotonin syndrome due to an overdose of moclobemide and clomipramine. A potentially life-threatening association. Intensive Care Med. 1967;23(1):122–124. doi: 10.1007/s001340050303. [DOI] [PubMed] [Google Scholar]
  • 25.Ferrer-Dufol A, Perez-Aradros C, Murillo EC, Marques-Alamo JM. Fatal serotonin syndrome caused by moclobemide-clomipramine overdose. J Toxicol Clin Toxicol. 1998;36(1-2):31–32. doi: 10.3109/15563659809162580. [DOI] [PubMed] [Google Scholar]

Articles from São Paulo Medical Journal are provided here courtesy of Associação Paulista de Medicina

RESOURCES